» Articles » PMID: 29042944

Pien Tze Huang Induces Apoptosis and Inhibits Proliferation of 5-fluorouracil-resistant Colorectal Carcinoma Cells Via Increasing MiR-22 Expression

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2017 Oct 19
PMID 29042944
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The well-known traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used to treat various malignancies, including colorectal cancer (CRC). It was recently reported that PZH possesses the ability to overcome multidrug resistance in CRC cells. In the present study, a 5-fluorouracil (5-FU) resistant human CRC cell line (HCT-8/5-FU) was used to further evaluate the effect of PZH on chemotherapy (chemo)-resistance and investigate the mechanisms through which this occurs. The results identified that PZH significantly reduced the viability and cell density of HCT-8/5-FU cells in a dose- and time-dependent manner (P<0.05). PZH inhibited cell survival, reduced the proportion of cells in S-phase, and suppressed the expression of pro-proliferative proteins cyclin D1 and cyclin-dependent kinase 4. In addition, PZH treatment induced nuclear condensation and fragmentation, activated caspase-9 and -3 and increased the pro-apoptotic Bcl-2-associated X protein/B-cell lymphoma 2 protein ratio. Furthermore, PZH treatment upregulated the expression of microRNA-22 (miR-22) and downregulated the expression of c-Myc (a target gene of miR-22). In conclusion, the findings from the present study suggest that PZH can overcome chemo-resistance in cancer cells, likely through increasing miR-22 expression, and by reversing the imbalance between levels of proliferation and apoptosis.

Citing Articles

Pien-tze-huang promotes wound healing in streptozotocin-induced diabetes models associated with improving oxidative stress the Nrf2/ARE pathway.

Liu Y, Mo J, Liang F, Jiang S, Xiong J, Meng X Front Pharmacol. 2023; 14:1062664.

PMID: 36713837 PMC: 9878590. DOI: 10.3389/fphar.2023.1062664.


Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism.

Wei J, Liu Z, He J, Liu Q, Lu Y, He S Clin Transl Oncol. 2021; 24(3):471-482.

PMID: 34643878 DOI: 10.1007/s12094-021-02716-4.


Deciphering Antitumor Mechanism of Pien Tze Huang in Mice of Hepatocellular Carcinoma Based on Proteomics.

Fan D, Liu C, Li L, Lu C, Zhao N, Shu J J Immunol Res. 2020; 2020:4876251.

PMID: 33344655 PMC: 7728492. DOI: 10.1155/2020/4876251.


Uncovering the Mechanism of the Effects of on Liver Cancer Using Network Pharmacology and Molecular Docking.

Liu S, Wang R, Lou Y, Liu J Evid Based Complement Alternat Med. 2020; 2020:4863015.

PMID: 32963562 PMC: 7492898. DOI: 10.1155/2020/4863015.


Therapeutic Potential of Pien-Tze-Huang: A Review on Its Chemical Composition, Pharmacology, and Clinical Application.

Huang L, Zhang Y, Zhang X, Chen X, Wang Y, Lu J Molecules. 2019; 24(18).

PMID: 31505740 PMC: 6767116. DOI: 10.3390/molecules24183274.


References
1.
Chen Y, McGee J, Chen X, Doman T, Gong X, Zhang Y . Identification of druggable cancer driver genes amplified across TCGA datasets. PLoS One. 2014; 9(5):e98293. PMC: 4038530. DOI: 10.1371/journal.pone.0098293. View

2.
He F, Wu H, Cai M, Li C, Zhang X, Wan Q . Inhibition of ovarian cancer cell proliferation by Pien Tze Huang via the AKT-mTOR pathway. Oncol Lett. 2014; 7(6):2047-2052. PMC: 4049676. DOI: 10.3892/ol.2014.1989. View

3.
Lippman S . The dilemma and promise of cancer chemoprevention. Nat Clin Pract Oncol. 2006; 3(10):523. DOI: 10.1038/ncponc0609. View

4.
Longley D, Allen W, Johnston P . Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim Biophys Acta. 2006; 1766(2):184-96. DOI: 10.1016/j.bbcan.2006.08.001. View

5.
Shen A, Lin W, Chen Y, Liu L, Chen H, Zhuang Q . Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network. Int J Oncol. 2014; 46(2):685-90. DOI: 10.3892/ijo.2014.2772. View